Cero Therapeutics Holdings Inc Share Price

NASDAQ: CERO

Small Cap

$5.41

-0.09

(-1.64%)

as on September 13, 2025 at 1:29 am IST

$₹

Cero Therapeutics Holdings Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$5.3
Day's Price Range
$5.6
$5.41
2.03%
Downside
3.51%
Upside
52 Week's Low
52 Week's High
$4.27
52-Week Price Range
$895.4
$5.41
21.07%
Downside
16450.83%
Upside

Cero Therapeutics Holdings Inc share price movements today

Previous Close: $5.50
Open: $5.60
Volume: 557.7K
Day's Low - High: $5.3 - $5.6
52 Week Low - High: $4.27 - $895.4

Cero Therapeutics Holdings Inc Historical Returns

1 Month Return: -34.78 %
3 Month Return: -26.13 %
1 Year Return: -97.1 %
3 Year Return: 0 %
5 Year Return: 0 %

Cero Therapeutics Holdings Inc Stock Fundamentals & Key Indicators

Check Cero Therapeutics Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.0M

EPS (TTM)

-15.39

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

606500.00%

Cero Therapeutics Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cero Therapeutics Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cero Therapeutics Holdings Inc	NA	$6.0M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Stock Returns calculator for Cero Therapeutics Holdings Inc Stock including INR - Dollar returns

The Cero Therapeutics Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cero Therapeutics Holdings Inc investment value today

Current value as on today

₹8,041

Returns

₹91,959

(-91.96%)

Returns from Cero Therapeutics Holdings Inc Stock

₹97,098 (-97.1%)

Dollar Returns*

₹5,139 (+5.14%)

Cero Therapeutics Holdings Inc Stock's Interest Amongst Investors

Search interest for Cero Therapeutics Holdings Inc Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 15, 2025 to September 14, 2025

Change:11% versus previous 30 day period

Cero Therapeutics Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Jun 2024	Sep 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	1	-
Gross Profit	-	-	0	0	0	0	0	-
Operating Income	0	-1	0	0	-5	-4	-4	-4
EBITDA	-2	-2	0	0	-2	-4	-4	-5
Interest Expense	-	-	-	-	0	-	0	0
Depreciation	0	0	0	0	-	-	0	0
Income Before Tax	0	-1	0	0	-2	-4	-5	-5
Income Tax Expense	0	0	0	0	0	-4	0	-
Net Income	-2	-2	0	0	-2	-4	-5	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-439.10%	0.00%

Cero Therapeutics Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023
Total Revenue	-	-	-
Gross Profit	-	-	-1
Operating Income	0	-2	-2
EBITDA	0	0	-2
Interest Expense	-	-	-
Depreciation	0	1	1
Income Before Tax	0	0	-2
Income Tax Expense	0	0	0
Net Income	0	0	0
Net Profit Margin	0.00%	0.00%	0.00%

Cero Therapeutics Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025
Net Income	-2	-2	0	0	-2	-2	0	-5	-5
Operating Cash Flow	-1	-2	0	0	-5	-3	-2	-4	-4
Investing Cash Flow	-	0	5	-13	-	-	0	0	-
Financing Cash Flow	0	0	-5	0	7	2	2	6	2
Change in Cash	-1	-1	0	1	2	0	0	1	-1

Cero Therapeutics Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024
Net Income	-11	-7	-8
Operating Cash Flow	-1	-5	-5
Investing Cash Flow	180	0	-
Financing Cash Flow	-138	0	0
Change in Cash	41	-5	-5

Insights on Cero Therapeutics Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 169.3%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 172.8%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CERO stock has moved down by -7.4%

About Cero Therapeutics Holdings Inc

CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body’s full immune repertoire to achieve optimized cancer therapy. This novel cellular immunotherapy platform is designed to redirect patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating what the Company refers to as Chimeric Engulfment Receptor T cells (CER-T). Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand. The Company is initiating clinical trials for its lead product candidate, CER-1236, for hematological malignancies.

Organisation	Cero Therapeutics Holdings Inc
Headquarters	201 Haskins Way, South San Francisco, CA, United States, 94080
CEO	Mr. Christopher B. Ehrlich M.B.A.
E-voting on shares	Click here to vote

Key Management of Cero Therapeutics Holdings Inc

Name	Title
Mr. Christopher B. Ehrlich M.B.A.	CEO & Chair
Mr. Andrew Albert Kucharchuk M.B.A.	Chief Financial Officer
Dr. Kristen Pierce Ph.D.	Chief Development Officer
Dr. Lawrence Corey M.D.	Co-founder & Head of Scientific Advisory Board

FAQs

What is Cero Therapeutics Holdings Inc share price today?

Cero Therapeutics Holdings Inc share price today is $5.41 as on September 13, 2025 at 1:29 am IST at the close of the market. Cero Therapeutics Holdings Inc share today touched a day high of $5.6 and a low of $5.3.

What is the 52 week high and 52 week low for Cero Therapeutics Holdings Inc share?

Cero Therapeutics Holdings Inc share touched a 52 week high of $895.4 on November 15, 2024 and a 52 week low of $4.27 on September 8, 2025. Cero Therapeutics Holdings Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $5.41,which is 99.40% down from its 52 week high and 26.69% up from its 52 week low.

What is Cero Therapeutics Holdings Inc's market capitalisation today?

Cero Therapeutics Holdings Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Cero Therapeutics Holdings Inc Stock (CERO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cero Therapeutics Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cero Therapeutics Holdings Inc Shares that will get you 0.2773 shares as per Cero Therapeutics Holdings Inc share price of $5.41 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cero Therapeutics Holdings Inc Stock (CERO) from India?

Indian investors can start investing in Cero Therapeutics Holdings Inc (CERO) shares with as little as ₹88.27 or $1 (as of September 14, 2025 at 6:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Cero Therapeutics Holdings Inc stock (as per the Rupee-Dollar exchange rate as on September 14, 2025 at 6:39 am IST). Based on Cero Therapeutics Holdings Inc share’s latest price of $5.41 as on September 13, 2025 at 1:29 am IST, you will get 1.8484 shares of Cero Therapeutics Holdings Inc. Learn more about fractional shares .